An analysis of our dataset covering 195 million lives revealed that 6.26 million individuals are living with type 2 diabetes. Alarmingly, 21% of these patients, in our analysis, have an HbA1c level above 9, indicating poorly controlled diabetes. This means that 1 in 5 individuals are at high risk—many of whom may be unaware they are approaching a critical threshold in their health.
For these high-risk type 2 diabetes patients, the opportunity to intervene is urgent.
These patients struggle with managing their blood sugar levels and face a heightened risk of severe complications such as heart disease, kidney failure, nerve damage, and vision loss. They are prime candidates for intervention, yet they often slip through the cracks of the healthcare system due to poor adherence to medication, lack of personalized support, or limited education on managing their condition.
Pharmaceutical companies have a unique opportunity to improve outcomes by targeting these 1.3 million patients and their treating providers directly. Through tailored omnichannel messaging and resources, they can empower patients to optimize their medications, improve blood sugar control, and reduce their risk of complications. Essence leverages real-world data to enable pharma marketers to engage and activate these patients and their providers with personalized messaging at critical points in their care journey, initiating meaningful health encounters that drive better outcomes.
Uncontrolled Type 2 diabetes often stems from poor disease management, including medication non-adherence, inadequate lifestyle changes, and underlying health conditions. This results in consistently high blood glucose levels, increasing the risk of severe complications. Essentially, their bodies are unable to effectively utilize insulin to lower blood sugar, making timely intervention and support even more critical in managing their condition.
By reaching the over 6.3 million patients in our database with personalized, timely support through the Essence network, pharma can help reduce the burden of uncontrolled diabetes, promote better health outcomes, and enhance quality of life for millions of people.